We are live on ! Find out more
CTKB icon

Cytek Biosciences
CTKB

84 hedge funds and large institutions have $568M invested in Cytek Biosciences in 2022 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 17

86% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 14

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

14% more funds holding

Funds holding: 74 → 84 (+10)

10% more capital invested

Capital invested by funds: $515M → $568M (+$53.3M)

3.78% more ownership

Funds ownership: 35.59% → 39.37% (+3.8%)

Holders
84
Holders Change
+10
Holders Change %
+13.51%
% of All Funds
1.42%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
26
Increased
36
Reduced
17
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BWLSA
Blue Water Life Science Advisors
California
+$20.9M
2
BlackRock
BlackRock
New York
+$10.4M
3
RI
RTW Investments
New York
+$9.13M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$9.01M
5
Millennium Management
Millennium Management
New York
+$7.81M

Top Sellers

Rank Fund Capital Flow
1
MGM
Miura Global Management
New York
-$6.03M
2
Goldman Sachs
Goldman Sachs
New York
-$5.72M
3
Two Sigma Investments
Two Sigma Investments
New York
-$5.65M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$5.21M
5
Bank of America
Bank of America
North Carolina
-$2.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
76
Wells Fargo
California
$27K -$356K -35,806 -93%
Nisa Investment Advisors
77
Nisa Investment Advisors
Missouri
$18K +$16.9K +1,700 New
Royal Bank of Canada
78
Royal Bank of Canada
Ontario, Canada
$7K -$53.3K -5,351 -89%
PNC Financial Services Group
79
PNC Financial Services Group
Pennsylvania
$5K – – –
CAPTRUST Financial Advisors
80
CAPTRUST Financial Advisors
North Carolina
$4K -$259 -26 -7%
UBS Group
81
UBS Group
Switzerland
$1K +$627 +63 New
CA
82
Crewe Advisors
Utah
$1K +$766 +77 New
EI
83
Ellevest Inc
New York
$1K +$1.11K +112 New
Two Sigma Investments
84
Two Sigma Investments
New York
– -$5.65M -524,421 Closed
SCM
85
Soleus Capital Management
Connecticut
– -$1.94M -180,000 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
86
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$1.37M -126,800 Closed
Walleye Capital
87
Walleye Capital
New York
– -$1.05M -97,852 Closed
Two Sigma Advisers
88
Two Sigma Advisers
New York
– -$1.02M -95,000 Closed
Wellington Management Group
89
Wellington Management Group
Massachusetts
– -$449K -41,617 Closed
PP
90
Paloma Partners
Connecticut
– -$439K -40,751 Closed
JF
91
Jump Financial
Illinois
– -$376K -34,854 Closed
EGM
92
Engineers Gate Manager
New York
– -$354K -32,799 Closed
ECM
93
ExodusPoint Capital Management
New York
– -$292K -27,049 Closed
Susquehanna International Group
94
Susquehanna International Group
Pennsylvania
– -$254K -23,590 Closed
GCM
95
Graham Capital Management
Connecticut
– -$214K -19,884 Closed
PHK
96
Point72 Hong Kong
Hong Kong
– -$132K -12,250 Closed
C
97
Covestor
United Kingdom
– -$60 -6 -25%
Osaic Holdings
98
Osaic Holdings
Arizona
– +$199 +20 New
1 2 3
4

CTKB Hedge Fund Activity: Q2 2022 in Review

84 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cytek Biosciences (CTKB) for Q2 2022, worth a combined $568M — up 10% from $515M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new CTKB positions and 14 closed out — a net gain of 12 holders — while 36 added to existing stakes and 17 trimmed.

The largest buyer was Blue Water Life Science Advisors, opening a new position worth an estimated $20.9M. The largest seller was Miura Global Management, cutting an estimated $6.03M.

  • 84 institutional investors held Cytek Biosciences (CTKB) as of Q2 2022, up from 74 in Q1 2022.
  • Funds reported $568M of Cytek Biosciences stock for Q2 2022, up 10% quarter-over-quarter.
  • 26 funds opened new Cytek Biosciences positions in Q2 2022 and 14 closed out, a net change of +12 holders.
  • The largest Cytek Biosciences buyer in Q2 2022 was Blue Water Life Science Advisors, an estimated $20.9M added.
  • The largest Cytek Biosciences seller in Q2 2022 was Miura Global Management, an estimated $6.03M sold.

Based on aggregated 13F filings for Q2 2022.